ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer

Yan, Xiuchun; Dai, Junzhu; Han, Ying; You, Qi*; Liu, Yao*哈尔滨医科大学; y
DISEASE MARKERS2022-6-3DOI: 10.1155/2022/2478551
1被引12阅读
引用收藏
分享

摘要

Gastric cancer (GC) is one of the most common upper gastrointestinal malignant tumors, and the incidence of the GC shows an increasing trend in the past years. Finding more sensitive markers will help to reveal the mechanism of GC progression and clinic diagnoses. This study first analyzed the mRNA expression level of FSIP1 in TCGA GC samples and the significance in predicting the prognosis. KEGG and GO analyses were used to explore the molecular mechanism of FSIP1 in GC progression. This study further retrospectively analyzed 166 clinical samples of GC from Harbin Medical University Cancer Hospital and evaluated the expression level of FSIP1 by immunohistochemistry. Kaplan-Meier and Cox multivariate analysis was used to investigate the prognostic value of FSIP1 expression in GC patients. We also identified correlations between FSIP1 and clinicopathological characteristics. This study found that the mRNA level of FSIP1 was significantly upregulated in GC compared with nontumor specimens and correlated with poor prognosis. Immunohistochemistry confirmed the results of bioinformatics analysis of the TCGA GC database. FSIP1 was associated with pTNM pathological stage, tumor location, and neural invasion. In addition, multivariate Cox regression analysis showed that FSIP1, T classification, and N classification were independent posterior factors of patients and could be combined with pathological features to construct a nomogram prognostic model. Overall, our results suggest that FSIP1 is expected to be an independent prognostic indicator of GC.

学科与关键词

关键词
FIBROUS SHEATHSTATISTICSPROTEINSANTIGENTRENDSAKAP-4
相关
加载中…
  • Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
    Peng, Ke; Li, Suyao; Li, Qian; Zhang, Chenlu; Yuan, Yitao; Liu, Menglin; Zhang, Lei; Wang, Yichen; Yu, Shan; Zhang, Haisheng*; Liu, Tianshu*Frontiers in Oncology, 2022, 12: 953938.被引 1
  • Clinical and Biological Significances of FBLN5 in Gastric Cancer
    Bian, Xiulan; Yin, Shengjie; Yin, Xin; Fang, Tianyi; Wang, Yufei; Yang, Shuo; Jiang, Xinju; Xue, Yingwei; Ye, Fei*; Zhang, Lei*Cancers, 2023, 15(2): 553.被引 1
  • HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
    Jiang, Rui; Wang, Jinghua; Liang, Jun; Lin, Daihua; Mao, Qiuxian; Cheng, Siyi; Huang, Shengjun; Tong, Shuangshuang; Lyu, Yanlin; Wei, Rui; Lian, Qizhou*; Chen, Hao*Frontiers in Pharmacology, 2023, 13: 1096055.
查看全部 →

发表信息

论文状态
公开发表
期刊
DISEASE MARKERS
发表日期
2022-06-03
卷期
第 2022 卷
页码
2478551
DOI
10.1155/2022/2478551
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Heilongjiang Postdoctoral Fund of Heilongjiang Province [LBH-Z16101]; Heilongjiang Province Postdoctoral Research Start-up Fund [LBH-Q19123]

作者

  • Y

    Yan, Xiuchun (第一作者)

    harbin med univ

  • D

    Dai, Junzhu

    harbin med univ

查看全部 5 位作者收起作者
  • H

    Han, Ying

    harbin med univ

  • Y

    You, Qi (通讯)

    harbin med univ

  • L

    Liu, Yao (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417